Intravascular Hemolysis

Overview


Plain-Language Overview

Intravascular hemolysis is a condition where red blood cells break down inside the blood vessels, releasing their contents directly into the bloodstream. This affects the blood and circulatory system, leading to symptoms like fatigue, jaundice, and dark urine due to the release of hemoglobin. The breakdown of red blood cells can cause anemia, which means the body has fewer cells to carry oxygen. It can also lead to complications such as kidney damage because the free hemoglobin can be harmful to the kidneys. The condition often results from immune reactions, infections, or mechanical damage to red blood cells. Understanding this process helps explain why people with this condition may feel weak and have changes in their urine color.

Clinical Definition

Intravascular hemolysis is the pathological destruction of red blood cells within the vascular compartment, leading to the release of free hemoglobin into the plasma. This process is typically caused by mechanical trauma, complement-mediated lysis, or toxins that disrupt the red cell membrane integrity. The hallmark of this condition is the presence of hemoglobinemia and hemoglobinuria, which can cause downstream complications such as acute kidney injury due to hemoglobin-induced tubular toxicity. It is distinguished from extravascular hemolysis by the site of red cell destruction and the presence of schistocytes on peripheral smear. Common causes include microangiopathic hemolytic anemia, paroxysmal nocturnal hemoglobinuria, and transfusion reactions. Recognition of intravascular hemolysis is critical due to its potential to cause severe anemia and organ damage.

Inciting Event

Locked content

Latency Period

Locked content

Diagnostic Delay

Locked content

Clinical Presentation


Signs & Symptoms

Locked content

History of Present Illness

Locked content

Past Medical History

Locked content

Family History

Locked content

Physical Exam Findings

Locked content

Diagnostic Workup


Diagnostic Criteria

Locked content

Pathophysiology


Key Mechanisms

Locked content

Organs

Locked content

Tissues

Locked content

Cells

Locked content

Chemical Mediators

Locked content

Treatments


Pharmacological Treatments

Locked content

Non-pharmacological Treatments

Locked content

Prevention


Pharmacological Prevention

Locked content

Non-pharmacological Prevention

Locked content

Outcome & Complications


Complications

Locked content

Short-term Sequelae

Locked content

Long-term Sequelae

Locked content

Differential Diagnoses


Differentials

Locked content

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.